Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence

By sjmartinez • January 25, 2025

Krishnan S, Srivastava PK, Attaluri J, Nayeri R, Chatterjee D, Patel J, Nsair A, Budoff M, Nayeri A. Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence. J Cardiovasc Dev Dis. 2025 Jan 7;12(1):19. doi: 10.3390/jcdd12010019. PMID: 39852297; PMCID: PMC11766028.

Tags: Cardiology/Epi, GIP GLP-1 receptor agonist, Harbor UCLA, Hematology/Oncology, Metabolic syndrome, Obesity, Publications, semaglutide, tirzepatide, Veterans Administration, weight loss

Association of Mechanical Circulatory Support and Cardiac Catheterization Laboratory Procedural Volumes with Outcomes of Cardiogenic Shock

Tabibian K, Vadlakonda A, Coaston T, Sakowitz S, Ebrahimian S, Srivastava PK, Benharash P. Association of Mechanical Circulatory Support and Cardiac Catheterization Laboratory Procedural Volumes[...]

Reply: Keto CTA Study

Soto-Mota A, Norwitz NG, Manubolu VS, Kinninger A, Wood TR, Earls J, Feldman D, Budoff M. Reply: Keto CTA Study. JACC Adv. 2025 May 7;4(7):101862.[...]

Mild to moderate COPD, vitamin D deficiency, and longitudinal bone loss: The MESA study

Ghotbi E, Hathaway QA, Hadidchi R, Momtazmanesh S, Bancks MP, Bluemke DA, Barr RG, Post WS, Budoff M, Smith BM, Lima JAC, Demehri S. Mild[...]